These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15219186)

  • 1. Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents.
    Iorio A
    J Thromb Haemost; 2004 Jul; 2(7):1055-7. PubMed ID: 15219186
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis.
    Mismetti P; Laporte S; Zufferey P; Epinat M; Decousus H; Cucherat M
    J Thromb Haemost; 2004 Jul; 2(7):1058-70. PubMed ID: 15219187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of venous thromboembolism after major orthopedic surgery: 'new' clinical trials for new antithrombotic agents.
    Mismetti P
    J Thromb Haemost; 2003 Dec; 1(12):2474-6. PubMed ID: 14675081
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronicity of hypercoagulative state: a favourable evidence for postoperative prolongation of antithrombotic prophylaxis].
    Iturbe Hernández T; Cornudella Lacasa R; Moreno Chulilla JA; Gutiérrez Martín M
    Med Clin (Barc); 2003 Apr; 120(14):559. PubMed ID: 12724070
    [No Abstract]   [Full Text] [Related]  

  • 5. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    Turpie AG; Bauer KA; Eriksson BI; Lassen MR
    Lancet; 2003 Nov; 362(9395):1582-3. PubMed ID: 14615120
    [No Abstract]   [Full Text] [Related]  

  • 6. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    Bounameaux H
    Lancet; 2003 Nov; 362(9395):1581; author reply 1582. PubMed ID: 14615118
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of venous thromboembolism after orthopedic surgery: the EXPRESS study.
    Cimminiello C; Planès A; Samama MM
    J Thromb Haemost; 2004 Nov; 2(11):2036-40. PubMed ID: 15550036
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of venous thromboembolism: duration and new options.
    Huisman MV
    Hematol J; 2004; 5 Suppl 3():S24-8. PubMed ID: 15190273
    [No Abstract]   [Full Text] [Related]  

  • 9. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    ten Cate H
    Lancet; 2003 Nov; 362(9395):1581; author reply 1582. PubMed ID: 14615119
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter 2: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Tangelder MJ; Bylock A; Held P
    Br J Surg; 2006 Mar; 93(3):374-5; author reply 375-6. PubMed ID: 16498578
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter 3: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Agnelli G; Bergqvist D; Dahl O; Eriksson B; Rud Lassen M; Mouret P; Rosencher N
    Br J Surg; 2006 Mar; 93(3):375; author reply 375-6. PubMed ID: 16498579
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis of venous thromboembolism in orthopaedic surgery.
    Abad JI
    Pathophysiol Haemost Thromb; 2002; 32(5-6):403-5. PubMed ID: 13679686
    [No Abstract]   [Full Text] [Related]  

  • 13. More on: Prevention of venous thromboembolism after orthopedic surgery: the EXPRESS study.
    Eriksson BI
    J Thromb Haemost; 2005 Mar; 3(3):611-2. PubMed ID: 15748270
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standards and perspectives for thromboembolism prophylaxis].
    Rader CP
    Orthopade; 2007 Jun; 36(6):560, 562-6. PubMed ID: 17546440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of thromboembolic disease: an overview.
    Westrich GH; Sánchez PM
    Instr Course Lect; 2002; 51():471-80. PubMed ID: 12064136
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery.
    Agnelli G; Sonaglia F; Becattini C
    Curr Pharm Des; 2005; 11(30):3885-91. PubMed ID: 16305519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolonged out-of-hospital prophylaxis of venous thromboembolism].
    Castells X; Vallano A
    Med Clin (Barc); 2002 Jun; 119(2):73-4. PubMed ID: 12084374
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cost-effectiveness analysis of enoxaparin for the prophylaxis of venous thromboembolism in major orthopedic surgery patients].
    Brosa Riestra M; Rubio-Terrés C; Nadipelli V; Casado Collado A; Martínez Brotons F
    Farm Hosp; 2003; 27(4):210-8. PubMed ID: 12966450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
    Turpie AG; Bauer KA; Eriksson BI; Lassen MR
    Arch Intern Med; 2002 Sep; 162(16):1833-40. PubMed ID: 12196081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.